Literature DB >> 3533746

Aggressive angiofollicular lymph node hyperplasia (Castleman's disease) treated with high dose melphalan and autologous bone marrow transplantation.

L Repetto, M P Jaiprakash, P J Selby, B A Gusterson, H J Williams, T J McElwain.   

Abstract

A case of aggressive widespread angiofollicular lymph node hyperplasia in a 42-year-old male, treated with high dose melphalan is presented. The disease had failed to enter a durable remission after chemotherapy. High dose melphalan with autologous bone marrow transplantation achieved a complete remission which has lasted for 15 months to date. This approach can be considered when other measures fail.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3533746     DOI: 10.1002/hon.2900040305

Source DB:  PubMed          Journal:  Hematol Oncol        ISSN: 0278-0232            Impact factor:   5.271


  6 in total

Review 1.  Transplantation in rare lymphoproliferative and histiocytic disorders.

Authors:  Alexis Cruz-Chacon; John Mathews; Ernesto Ayala
Journal:  Cancer Control       Date:  2014-10       Impact factor: 3.302

Review 2.  Castleman's disease: from basic mechanisms to molecular therapeutics.

Authors:  Hazem E El-Osta; Razelle Kurzrock
Journal:  Oncologist       Date:  2011-03-25

3.  Autologous stem cell transplantation in a rare multicentric Castleman disease of the plasma cell variant.

Authors:  Yuval Tal; Guy Haber; Matan J Cohen; Micci Phillips; Gail Amir; Dina Ben-Yehuda; Arie Ben-Yehuda
Journal:  Int J Hematol       Date:  2011-03-26       Impact factor: 2.490

4.  Cases report of unicentric Castleman's disease: revisit of radiotherapy role.

Authors:  O Kyu Noh; Sang-Wook Lee; Jae Whan Lee; Sang Yoon Kim; Chung Soo Kim; Eun Kyung Choi; Jong Hoon Kim; Seung Do Ahn
Journal:  Radiat Oncol J       Date:  2013-03-31

Review 5.  Treatment of Castleman's disease.

Authors:  Angela Dispenzieri; Morie A Gertz
Journal:  Curr Treat Options Oncol       Date:  2005-05

Review 6.  Update and new approaches in the treatment of Castleman disease.

Authors:  Kah-Lok Chan; Stephen Lade; H Miles Prince; Simon J Harrison
Journal:  J Blood Med       Date:  2016-08-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.